Strategic Overview

Antrum Biotech develops IRISA-TB, an immunological test for TB diagnosis from pleural and CSF samples.

Innovation Portfolio

IRISA-TB
Category: SCREENING Stage: Late Stage

Innovative diagnostic solution.

Biomarker Pleural/CSF

Key Milestones

IRISA-TB biomarker test
89% sensitivity in pleural TB
Suitable for extra-pulmonary TB diagnosis
District-level capability